In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC

International Journal of Pharmaceutics

Volumn 367, Issue 1-2, 2009, Pages 148-154

  Bouquet, W ^a   Boterberg, T ^a   Ceelen, W ^b   Pattyn, P ^b   Peeters, M ^b   Bracke, M ^a   Remon, J P ^a   Vervaet, C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cyclodextrin; Cytotoxicity; Hyperthermic intraperitoneal chemotherapy (HIPEC); MTT; Paclitaxel; SRB

Indexed keywords

BETA CYCLODEXTRIN; CREMOPHOR; EXCIPIENT; PACLITAXEL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CELL STRAIN CACO 2; CELL VIABILITY; COLON CANCER; CYTOTOXICITY; DRUG FORMULATION; HUMAN; HUMAN CELL; HYPERTHERMIA; HYPERTHERMIC THERAPY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETA-CYCLODEXTRINS; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COMBINED MODALITY THERAPY; DRUG CARRIERS; EXCIPIENTS; HOT TEMPERATURE; HUMANS; HYPERTHERMIA, INDUCED; PACLITAXEL; PERITONEAL NEOPLASMS; RATS;

EID: 58249118815     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.035     Document Type: Article

References (26)

1. Alcaro S., Ventura C.A., Paolino D., Battaglia F., Ortuso F., Cattel L., Puglisi G., and Fresta M. Preparation, characterization, molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes. Bioorg. Med. Chem. 12 (2002) 1637-1641
2. Bartlett D.L., Ma G., Alexander H.R., Libutti S.K., and Fraker D.L. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer 80 (1997) 2084-2090
3. Bartlett D.L., Buell J.F., Libutti S.K., Reed E., Lee K.B., Figg W.D., Venzon D.J., and Alexander H.R. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer 83 (1998) 1251-1261
4. Bouquet W., Ceelen W., Fritzinger B., Pattyn P., Peeters M., Remon J.P., and Vervaet C. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion-formulation and stability. Eur. J. Pharm. Biopharm. 66 (2007) 391-397
5. Ceelen W.P., Hesse U., de Hemptinne B., and Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br. J. Surg. 87 (2000) 1006-1015
6. Cividalli A., Cruciani G., Lividi E., Pasqualetti P., and Tirindelli Danesi D. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 44 (1999) 407-412
7. ®): role of the solvent cremophor EL/ethanol. Anticancer Res. 18 (1998) 1851-1857
8. Dumontet C., Bodin F., and Michal Y. Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance. Clin. Cancer Res. 4 (1998) 1563-1566
9. Faheez M., Marchettini P., Stuart A., Urano M., and Sugarbaker P.H. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann. Surg. Oncol. 10 (2003) 463-468
10. Fjällskog M.L., Frii L., and Bergh J. Paclitaxel-induced cytotoxicity-the effects of Cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein. Eur. J. Cancer 30A (1994) 687-690
11. Gelderblom H., Verweij J., Nooter K., and Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37 (2001) 1590-1598
12. Grosse P.Y., Bressolle F., and Pinguet F. Antiproliferative effect of methyl-β-cyclodextrin in vitro and in human tumour xenografted athymic nude mice. Br. J. Cancer 78 (1998) 1165-1169
13. Jacquet P., Averbach A., Stuart O.A., Chang D., and Sugarbaker P.H. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother. Pharmacol. 41 (1998) 147-154
14. ®) in human tumor cell lines. Cancer Chemother. Pharmacol. 33 (1994) 331-339
15. Machover D.A. A comprehensive review of 5-fluoracil and leucovorin in patients with metastatic colorectal carinoma. Cancer 80 (1997) 1179-1187
16. McQuellon R.P., Loggie B.W., Fleming R.A., Russel G.B., Lehman A.B., and Rambo T.D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur. J. Surg. Oncol. 27 (2001) 65-73
17. Michalakis J., Georgatos S.D., de Bree E., Polioudaki H., Romanos J., Georgoulias V., Tsiftis D.D., and Theodoropoulos P.A. Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. Ann. Surg. Oncol. 14 (2007) 1220-1228
18. Minsky B.D., Mies C., Rich T.A., Recht A., and Chaffey J.T. Potentially curative surgery of colon cancer: patterns of failure and survival. J. Clin. Oncol. 6 (1988) 106-118
19. Othman T., Goto S., Lee J.B., Taimura A., Matsumoto T., and Kosaka M. Hypertermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 62 (2001) 208-212
20. Pestieau S.R., Stuart O.A., Chang D., Jacquet P., and Sugarbaker P.H. Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Tumori 84 (1998) 706-711
21. ®) on human renal clear cell carcinomas in vitro. Eur. J. Cancer 33 (1997) 1122-1129
22. Rietbroek R.C., Katschinski D.M., Reijers M.H.E., Robins H.I., Geerdink A., Tutsch K., D'Oleire F., and Haveman J. Lack of thermal enhancement for taxanes in vitro. Int. J. Hyperthermia 13 (1997) 525-533
23. Szente L., Vikmon M., Szemán J., and Otta K. Methyl-β-cyclodextrin/paclitaxel aqueous solutions: a tool to test Cremophor-free paclitaxel. STP Pharm. Sci. 9 (1999) 243-247
24. Teicher B.A., Kowal C.D., Kennedy K.A., and Sartorelli A.C. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res. 41 (1981) 1096-1099
25. van Zuylen L., Verweij J., and Sparreboom A. Role of formulation vehicles in taxane pharmacology. Invest. New Drugs 19 (2001) 125-141
26. Witkamp A.J., de Bree E., Van Goethem A.R., and Zoetmulder F.A.N. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat. Rev. 27 (2001) 365-374